News Results for Bioventix (BVXP)

  • 28 Oct
    15:45
    Director Deals - Bioventix Plc (BVXP)

    Ian Nicholson, Chairman, sold 2,500 shares in the company on the 25th October 2019 at a price of 3158.67p. The Director now holds 15,500 shares. Story provided by StockMarketWire.com Director...

  • 21 Oct
    13:41
    Bioventix profit nudges up 1% on higher antibody sales

    Antibody supplier Bioventix posted a 1% rise in annual profit amid rising sales of a vitamin D antibody to diagnostic companies. Pre-tax profit for the year through June rose to £7.0m, up from...

  • 21 Oct
    08:20
    Broker Forecast - finnCap issues a broker note on Bioventix Plc

    finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and raised its price target to 3750p (from 3700p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 29 Mar
    10:11
    Bioventix declares maiden interim dividend as profits shine brightly on higher Vitamin D sales

    Bioventix said declared its maiden interim dividend after profits rose by nearly a quarter as Vitamin D antibody sales continued at the 'healthy levels.' For the half, profits before tax increased...

  • 29 Mar
    08:20
    Broker Forecast - finnCap issues a broker note on Bioventix Plc

    finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and raised its price target to 3700p (from 3400p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 26 Mar
    09:20
    Broker Forecast - finnCap issues a broker note on Bioventix Plc

    finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and raised its price target to 2650p (from 2600p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 20 Oct
    14:35
    Director Deals - Bioventix Plc (BVXP)

    Ian Nicholson, Chairman, sold 5,000 shares in the company on the 19th October 2017 at a price of 2400.75p. The Director now holds 18,000 shares. Story provided by StockMarketWire.com Director...

  • 20 Oct
    14:35
    Director Deals - Bioventix Plc (BVXP)

    Peter Harrison, Chief Executive Officer, sold 80,000 shares in the company on the 19th October 2017 at a price of 2425.00p. The Director now holds 428,176 shares. Story provided by...

  • 16 Oct
    08:40
    Broker Forecast - finnCap issues a broker note on Bioventix Plc

    finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and set its price target at 2600p. Story provided by StockMarketWire.com

  • 16 Oct
    07:44
    Bioventix pre-tax profits up 37%

    Pre-tax profits at Bioventix rose by 37% to £5.7m in the year to the end of June. Revenues rose by 31% to £7.2m and were ahead of expectations. The group said the healthy performance of the...

  • 04 Sep
    08:24
    Bioventix ahead of forecasts

    Bioventix expects revenues for the year ended 30 June to be marginally in excess of £7m (2015-16: £5.5M). It said that since the cost-base of the company continued to follow a similar shallow...

  • 10 May
    09:17
    Bioventix to get royalties from Siemens troponin test

    Bioventix has described the launch of a new test by Siemens for troponin, a key biomarker used in heart attack diagnostics, as significant for the company. It said this test used antibodies...

  • 27 Mar
    09:50
    Broker Forecast - finnCap issues a broker note on Bioventix Plc

    finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and raised its price target to 1750p (from 1450p). Story provided by StockMarketWire.com

  • 27 Mar
    09:40
    Bioventix pre-tax profits rise

    Bioventix's pre-tax profits rose by 49% to £2.48m in the six months to the end of December. Turnover rose by 32% to £3.12m and after-tax profit increased by 41% to £1.98m. At 9:40am:...

  • 08 Dec
    08:52
    Bioventix resolutions passed at AGM

    Bioventix has confirmed that all resolutions put to shareholders at the annual general meeting yesterday were passed. At 8:52am: (LON:BVXP) Bioventix Plc share price was 0p at 1320p Story...

  • 17 Oct
    12:50
    Broker Forecast - finnCap issues a broker note on Bioventix Plc

    finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and raised its price target to 1450p (from 1350p). Story provided by StockMarketWire.com

  • 23 Aug
    11:00
    Broker Forecast - finnCap issues a broker note on Bioventix Plc

    finnCap today reaffirms its corporate investment rating on Bioventix Plc (LON:BVXP) and raised its price target to 1350p (from 1250p). Story provided by StockMarketWire.com

  • 22 Aug
    16:47
    Commodity prices weigh on FTSE

    The FTSE 100 was dragged lower by natural resource stocks as oil and metal prices got off to a bad start this week. The blue chip index closed 0.6% lower at 6,817. Royal Dutch Shell (RDSB)...

  • 22 Aug
    11:51
    FTSE holds ground amid summer lull

    London's FTSE 100 was stable at 6,864 with very little corporate news at the larger end of the market. The blue chip index saw small gains from banks, drug companies, housebuilders and utility...

  • 21 Mar
    10:50
    Broker Forecast - finnCap issues a broker note on Bioventix Plc Ord 5p

    finnCap today reaffirms its corporate investment rating on Bioventix Plc Ord 5p (LON:BVXP) and raised its price target to 1250p (from 1040p). Story provided by StockMarketWire.com

  • 20 Oct
    16:15
    Director Deals - Bioventix Plc Ord 5p (BVXP)

    Ian Nicholson, Chairman, sold 5,000 shares in the company on the 19th October 2015 at a price of 1115.00p. The Director now holds 27,000 shares. Story provided by StockMarketWire.com Director...

  • 05 Oct
    08:42
    Bioventix profits up 39%

    Bioventix - a company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics - posts pre-tax profits of £3.1m for...

  • 05 Oct
    07:16
    FLASH: Bioventix profits up

    Story provided by StockMarketWire.com

  • 04 Sep
    08:44
    FTSE indices southbound on retail after Asia falls

    FTSE indices surrendered the rump of yesterday's gain in early deals on what has so-far been a quiet Friday session. Blue-chip retailers were out of favour, as were several insurers and banks. Asia...

  • 04 Sep
    07:18
    BVXP performs

    Bioventix expects pretax profits for the year ended 30 June to be significantly ahead of market forecasts. The company said its core business remains robust and that revenues for the year are...

  • 04 Sep
    07:10
    FLASH: Bioventix core business remains robust

    Story provided by StockMarketWire.com

  • 30 Apr
    09:40
    Director Deals - Bioventix Plc Ord 5p (BVXP)

    Peter Harrison, Chief Executive Officer, sold 53,000 shares in the company on the 29th April 2015 at a price of 800.00p. The Director now holds 608,176 shares. Story provided by...

  • 30 Mar
    09:19
    Bioventix pre-tax profits up 31%

    Bioventix posts pre-tax profits of £1.26m for the six months to the end of December - 31% up on last time. Turnover rose by 28% to £1.9m and the interim dividend of 11p per share is up 15%....

  • 30 Mar
    07:29
    FLASH: Bioventix turnover up

    Story provided by StockMarketWire.com

  • 04 Dec
    09:32
    Bioventix resolutions passed at AGM

    Bioventix has confirmed that all resolutions put to shareholders at the annual general meeting yesterday were duly passed. At 9:32am: (LON:BVXP) Bioventix Plc Ord 5p share price was 0p at 720p...

  • 07 Oct
    08:18
    Bioventix pre-tax profits up 22%

    Bioventix posts pre-tax profits - after flotation and staff option costs - of £2.2m for the year to the end of June, 22% up on last time. Revenues rose by 31% to £3.5m and gross profits were...

  • 07 Oct
    07:18
    FLASH: Bioventix revenues up 31%

    Story provided by StockMarketWire.com

  • 21 Aug
    07:37
    Bioventix licensing agreement with DIAsource

    Bioventix has signed a license agreement with DIAsource ImmunoAssays of Belgium over certain intellectual property owned by DIAsource. In April, the company announced that it was taking action to...

  • 21 Aug
    07:09
    FLASH: Bioventix licensing agreement with DIAsource

    Story provided by StockMarketWire.com

  • 24 Apr
    08:48
    Bioventix pre-tax profits rise

    Bioventix posts pre-tax profits of £975,305 for the six months to the end of December - up from £736,646 a year ago. Turnover rose to £1.5m from £1.2m and gross profits increased to £1.3m...

  • 24 Apr
    07:07
    FLASH: Bioventix pre-tax profits rise

    Story provided by StockMarketWire.com

  • 11 Apr
    08:45
    Bioventix to join AIM

    Bioventix - a specialist in the development and commercial supply of high-affinity monoclonal antibodies with a primary focus on their application in clinical diagnostics - intends to move to AIM....

  • 01 Apr
    07:48
    Bioventix opposes patent

    Bioventix is opposing a European patent granted to DiaSource ImmunoAssays in the field of anti vitamin D antibodies and their use in tests for vitamin D sufficiency and deficiency. Chief executive...

  • 01 Apr
    07:11
    FLASH: Bioventix in patent opposition

    Story provided by StockMarketWire.com

  • 13 Feb
    11:08
    New director at Bioventix

    Bioventix has announced the appointment of Nick McCooke as a non-executive director. Mr. McCooke has worked in the biotech industry for over 25 years and is now an independent consultant providing...

  • 10 Feb
    08:23
    Bioventix options exercised

    Bioventix has applied for 12,411 ordinary shares to be admitted to trading on ISDX following the exercise of options by former employees. Story provided by StockMarketWire.com

  • 26 Sep
    07:53
    Bioventix after-tax profits up 23%

    Bioventix posts pre-profits of £1.8m for the year to the end of June - up from £1.5m last time. The company - which specialises in the development and commercial supply of high-affinity...

  • 26 Sep
    07:08
    FLASH: Bioventix after-tax profits up 23%

    Story provided by StockMarketWire.com

  • 27 Mar
    09:23
    Bioventix after-tax profits dip

    Bioventix posts after-tax profits of £630,160 for the six months to the end of December - down from £700,085 last time. The group - which specialises in the development and commercial supply of...

  • 27 Mar
    07:23
    FLASH: Bioventix after-tax profits dip

    Story provided by StockMarketWire.com

  • 09 Nov
    14:31
    Bioventix schedules AGM

    Bioventix will hold its annual general meeting at 7 Romans Business Park, Farnham, on 4 December at 2p.m. Story provided by StockMarketWire.com

  • 25 Sep
    07:47
    Bioventix pre-tax profits up 39%

    Bioventix pre-tax profits rose by 39% to £1.5m in the year to the end of June on revenues 21% higher at £2.4m. The company says the increase in pre-tax profits is due to the high margin nature...

  • 25 Sep
    07:04
    FLASH: Bioventix pre-tax profits up 39%

    Story provided by StockMarketWire.com

  • 12 Mar
    07:45
    Bioventix after-tax profits up 83%

    After-tax profits at Bioventix rose by 83% to £700,085 in the six months to the end of December. Bioventix - a company specialising in the development and commercial supply of high-affinity...

  • 12 Mar
    07:04
    FLASH: Bioventix after-tax profits up 83%

    Story provided by StockMarketWire.com

  • 04 Jan
    14:11
    Bioventix appoints finance director

    Bioventix has announced that Tim Cowper has left the board with immediate effect and that Treena Turner has been appointed as finance director. Turner is a partner with Wise & Co where she...

  • 13 Sep
    07:54
    Bioventix revenues up 25%

    Full-year revenues at Bioventix rose by 25% to £1.97m while pre-tax profits increased to £1.1m from £682,706 last time. Bioventix said the growth in sales to the multinational diagnostics...

  • 13 Sep
    07:08
    FLASH: Bioventix revenues up 25%

    Story provided by StockMarketWire.com

  • 07 Jan
    16:05
    Bioventix reveals research focus

    Bioventix's research focus this year will move towards progesterone - a fertility hormone - and benzodiazepines, a class of drug that includes well known entities such as temazepam, valium and...

  • 01 Dec
    10:01
    Bioventix develops novel antibody to Vitamin D

    Bioventix has announced a significant breakthrough in the creation of a unique antibody to vitamin D. The new antibody, called vitD3.5H10, could have significant utility in the manufacture of...

  • 01 Dec
    07:40
    FLASH: Bioventix develops novel antibody to Vitamin D

    Story provided by StockMarketWire.com

  • 02 Nov
    09:35
    Bioventix pre-tax profits fall

    Pre-tax profits at Bioventix fell to £682,706 in the year to the end of June - down from 2009's restated £857,080. Turnover fell slightly to £1.58m from £1.65m a year ago and gross profits were...

  • 02 Nov
    07:45
    FLASH: Bioventix pre-tax profits fall

    Story provided by StockMarketWire.com

  • 07 Apr
    09:51
    Bioventix first half profit; starts trading on PLUS

    Bioventix posts an interim pre-tax profit of £386,210 for the six months to the end of December on turnover of £768,419. Pre-tax profits for the year to the end of June was £857,080 on turnover of...

  • 07 Apr
    07:41
    FLASH: Bioventix interim pre-tax profit of £386,210

    Story provided by Business Financial Newswire

Shares Magazine

Shares Magazine

Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.

Special offer of 1 month for £1

Investor Events

Investor Events

Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.

Terms & Conditions | Privacy Policy | Cookies